Redmile as of June 30, 2013
Portfolio Holdings for Redmile
Redmile holds 49 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Align Technology (ALGN) | 6.8 | $39M | 1.0M | 37.04 | |
| Onyx Pharmaceuticals | 6.0 | $34M | 394k | 86.82 | |
| Clovis Oncology | 5.6 | $32M | 475k | 66.98 | |
| Cardinal Health (CAH) | 4.9 | $28M | 584k | 47.20 | |
| Hca Holdings (HCA) | 4.7 | $26M | 733k | 36.06 | |
| Puma Biotechnology (PBYI) | 4.2 | $24M | 540k | 44.37 | |
| Celgene Corporation | 4.1 | $24M | 201k | 116.98 | |
| Ariad Pharmaceuticals | 3.9 | $22M | 1.3M | 17.49 | |
| Array BioPharma | 3.8 | $22M | 4.8M | 4.54 | |
| Impax Laboratories | 3.4 | $19M | 961k | 19.94 | |
| NuVasive | 3.3 | $19M | 764k | 24.79 | |
| Insulet Corporation (PODD) | 3.2 | $18M | 573k | 31.41 | |
| HeartWare International | 2.7 | $15M | 162k | 95.11 | |
| Tenet Healthcare Corporation (THC) | 2.6 | $15M | 316k | 46.10 | |
| Brookdale Senior Living (BKD) | 2.5 | $14M | 547k | 26.44 | |
| Regeneron Pharmaceuticals (REGN) | 2.4 | $14M | 61k | 224.89 | |
| Zimmer Holdings (ZBH) | 2.4 | $13M | 178k | 74.94 | |
| Vanguard Health Systems | 2.4 | $13M | 642k | 20.74 | |
| Globus Med Inc cl a (GMED) | 2.1 | $12M | 701k | 16.86 | |
| Merck & Co (MRK) | 2.0 | $12M | 250k | 46.45 | |
| Model N (MODN) | 2.0 | $11M | 485k | 23.36 | |
| Cepheid | 1.9 | $11M | 319k | 34.42 | |
| Chimerix (CMRX) | 1.9 | $11M | 451k | 24.24 | |
| Allergan | 1.9 | $11M | 127k | 84.24 | |
| Cerus Corporation (CERS) | 1.9 | $11M | 2.4M | 4.42 | |
| Capital Senior Living Corporation | 1.8 | $10M | 423k | 23.90 | |
| Tornier Nv | 1.7 | $9.6M | 549k | 17.50 | |
| Waters Corporation (WAT) | 1.4 | $8.0M | 80k | 100.05 | |
| Neurocrine Biosciences (NBIX) | 1.4 | $7.8M | 581k | 13.38 | |
| VCA Antech | 1.3 | $7.3M | 278k | 26.09 | |
| Cyberonics | 1.3 | $7.2M | 139k | 51.96 | |
| Abiomed | 1.2 | $7.0M | 326k | 21.56 | |
| Orexigen Therapeutics | 1.2 | $7.0M | 1.2M | 5.84 | |
| Pacific Biosciences of California (PACB) | 1.1 | $6.2M | 2.5M | 2.53 | |
| Amicus Therapeutics (FOLD) | 1.0 | $5.5M | 2.4M | 2.33 | |
| BioSpecifics Technologies | 0.9 | $4.9M | 312k | 15.60 | |
| Chemocentryx | 0.6 | $3.6M | 255k | 14.14 | |
| Alexion Pharmaceuticals | 0.6 | $3.6M | 39k | 92.25 | |
| Cyclacel Pharmaceuticals | 0.6 | $3.2M | 1.1M | 2.95 | |
| Kythera Biopharmaceuticals I | 0.5 | $3.0M | 110k | 27.05 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.5 | $2.9M | 3.0M | 0.95 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.1 | $261k | 1.5k | 174.00 | |
| Market Vectors Etf Tr pharmaceutical | 0.1 | $296k | 6.5k | 45.54 | |
| Abbott Laboratories (ABT) | 0.0 | $251k | 7.2k | 34.86 | |
| UnitedHealth (UNH) | 0.0 | $210k | 3.2k | 65.62 | |
| Salix Pharmaceuticals | 0.0 | $218k | 3.3k | 66.06 | |
| Idenix Pharmaceuticals | 0.0 | $109k | 30k | 3.61 | |
| XenoPort | 0.0 | $62k | 13k | 4.96 | |
| Dynavax Technologies Corporation | 0.0 | $55k | 50k | 1.10 |
